Breaking News Instant updates and real-time market news.

GILD

Gilead

$64.43

-0.08 (-0.12%)

09:58
05/19/17
05/19
09:58
05/19/17
09:58

Gilead participates in a conference call with Leerink

Leerink hosts a conference call with management on May 25 at 11:30 am.

  • 19

    May

GILD Gilead
$64.43

-0.08 (-0.12%)

04/25/17
JMPS
04/25/17
NO CHANGE
JMPS
Johsnson &Johnson data positive for Achillion, says JMP Securities
JMP Securities analyst Liisa Bayko says that data on a triple combination HCV treatment presented by Johnson & Johnson (JNJ) yesterday is positive for Achillion (ACHN). The analyst noted that the triple combination includes Achillion's odalasvir and that the six week treatment regimen is shorter than the eight weeks required for Gilead's (GILD) Harvoni. The analyst says that Achillion's stock dropped sharply yesterday because there was disappointment over the combination's efficacy in genotype 3 patients. However, she says that such patients only represent 10% of the total, and she says that Achillion can "conservatively" obtain peak royalty revenue of about $100M from its drug. Bayko keeps a $13 price target and an Outperform rating on the shares.
04/25/17
WELS
04/25/17
NO CHANGE
WELS
Gilead Q1 results poised to beat expectations, says Wells Fargo
After analyzing prescription data for January and February, Wells Fargo says that prescriptions of Gilead's HIV and HCV drugs were tracking ahead of expectations. The firm says the company's Q1 results appear on track to beat expectations.
04/21/17
PIPR
04/21/17
NO CHANGE
PIPR
Overweight
Piper Jaffray 'encouraged' by Gilead ACC inhibitor data in NASH
Piper Jaffray analyst Joshua Schimmer said Gilead's GS-0976 program in the treatment of NASH are the company's "most interesting" and the just announced data for the ACC inhibitor in a 10 patient study are very encouraging. The analyst, who continues to believe that reducing lipids is a key component for treating NASH, added that long term safety for inhibition of ACC will be necessary before he can have confidence in the program's potential. He keeps an Overweight rating on Gilead shares.
03/20/17
JEFF
03/20/17
NO CHANGE
JEFF
Buy
Jefferies uncovers 'unnoticed' positive NASH data coming from Gilead
Jefferies analyst Brian Abrahams said his review of titles for the upcoming EASL meeting of the International Liver Congress appears to indicate that Gilead's ACC inhibitor GS-0976, which he calls "one of [the company's] least-talked-about assets in NASH," demonstrated significant positive effects in an as-yet-unreported phase 2 study. The analyst, who calls the presentation "unnoticed" and "not broadly discussed," believes the study may meaningfully de-risk a second NASH asset and could set the stage for increasing enthusiasm around Gilead's NASH program over the next 12 months. Abrahams keeps a Buy rating on Gilead shares. The ILC meeting is being held from April 19 to 23 in Amsterdam.

TODAY'S FREE FLY STORIES

ALXN

Alexion

$115.42

1.58 (1.39%)

14:31
05/23/17
05/23
14:31
05/23/17
14:31
Recommendations
Alexion analyst commentary  »

Alexion should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RBS

RBS

$6.95

0.09 (1.31%)

14:30
05/23/17
05/23
14:30
05/23/17
14:30
Options
Royal Bank of Scotland sees put buying »

Royal Bank of Scotland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

HON

Honeywell

$131.98

0.14 (0.11%)

14:29
05/23/17
05/23
14:29
05/23/17
14:29
Hot Stocks
Honeywell says spinoff of aerospace is 'intriguing concept' »

This comment was made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HON

Honeywell

$132.08

0.235 (0.18%)

14:25
05/23/17
05/23
14:25
05/23/17
14:25
Hot Stocks
Honeywell to shape portfolio changes over next 2-3 years »

Comments are from EPG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HLF

Herbalife

$69.44

-4 (-5.45%)

14:21
05/23/17
05/23
14:21
05/23/17
14:21
Technical Analysis
Technical Analysis: Herbalife falls on report China executive departs »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$80.28

10.21 (14.57%)

14:20
05/23/17
05/23
14:20
05/23/17
14:20
Options
Newsbots go Bungee jumping this afternoon »

Newsbots go Bungee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$122.18

0.52 (0.43%)

14:18
05/23/17
05/23
14:18
05/23/17
14:18
Hot Stocks
United Technologies CEO not interested in split »

Speaking at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

MOMO

Momo

$42.83

-0.75 (-1.72%)

14:17
05/23/17
05/23
14:17
05/23/17
14:17
Recommendations
Momo analyst commentary  »

Momo price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

$NSD

NASDAQ Market Internals

14:17
05/23/17
05/23
14:17
05/23/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
05/23/17
05/23
14:16
05/23/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$61.56

0.175 (0.29%)

14:12
05/23/17
05/23
14:12
05/23/17
14:12
Hot Stocks
A.M. Best affirms AIG credit ratings, removes from under review »

A.M. Best has removed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BWLD

Buffalo Wild Wings

$150.60

-2 (-1.31%)

14:11
05/23/17
05/23
14:11
05/23/17
14:11
Technical Analysis
Technical Analysis: Buffalo Wild Wings trades at session lows »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$131.96

0.12 (0.09%)

14:11
05/23/17
05/23
14:11
05/23/17
14:11
Earnings
Honeywell backs FY17 EPS view $6.90-$7.10, consensus $7.09 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HON

Honeywell

$131.98

0.14 (0.11%)

14:08
05/23/17
05/23
14:08
05/23/17
14:08
Earnings
Honeywell backs Q2 EPS view $1.75-$1.80, consensus $1.78 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

WRB

W. R. Berkley

$67.93

0.26 (0.38%)

14:05
05/23/17
05/23
14:05
05/23/17
14:05
Hot Stocks
Ca. Insurance Commissioner announces $12M settlement with W. R. Berkley »

California Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$13.70

0.205 (1.52%)

14:05
05/23/17
05/23
14:05
05/23/17
14:05
Hot Stocks
F.N.B. implements board succession plan, says CEO to become chairman »

F.N.B. Corp announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$16.10

0.14 (0.88%)

14:02
05/23/17
05/23
14:02
05/23/17
14:02
Hot Stocks
NRG Energy looks to reorganize GenOn debt »

Earlier today,NRG Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$83.11

-0.94 (-1.12%)

14:00
05/23/17
05/23
14:00
05/23/17
14:00
Options
Bullish pre-earnings option play opened in Lowe's »

Bullish pre-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

BWLD

Buffalo Wild Wings

$150.60

-2 (-1.31%)

13:59
05/23/17
05/23
13:59
05/23/17
13:59
Hot Stocks
Buffalo Wild Wings issues presentation on Marcato's 'misleading statements' »

Buffalo Wild Wings, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

$60.90

0.55 (0.91%)

13:58
05/23/17
05/23
13:58
05/23/17
13:58
Hot Stocks
Taubman believes ISS, Glass Lewis 'erred' in their director recommendations »

Taubman Centers issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$61.66

-0.39 (-0.63%)

, SNAP

Snap

$20.08

-0.005 (-0.02%)

13:55
05/23/17
05/23
13:55
05/23/17
13:55
Hot Stocks
CBS to launch exclusives James Corden show on Snapchat »

CBS (CBS) Interactive and…

CBS

CBS

$61.66

-0.39 (-0.63%)

SNAP

Snap

$20.08

-0.005 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 01

    Jun

  • 15

    Jun

  • 28

    Jun

  • 19

    Jul

WERN

Werner

$26.35

0.5 (1.93%)

13:52
05/23/17
05/23
13:52
05/23/17
13:52
Hot Stocks
Werner sees 'story' of FY17 as a back half story »

Sees story of FY17 as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 07

    Jun

SNAP

Snap

$20.09

0.014 (0.07%)

, FB

Facebook

$148.24

0.18 (0.12%)

13:49
05/23/17
05/23
13:49
05/23/17
13:49
Hot Stocks
Snap rolls out new custom Stories feature »

Snapchat parent Snap…

SNAP

Snap

$20.09

0.014 (0.07%)

FB

Facebook

$148.24

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 24

    May

  • 01

    Jun

  • 28

    Jun

  • 19

    Jul

PAA

Plains All American

$27.83

-0.22 (-0.78%)

, PAGP

Plains GP Holdings

$28.27

-0.18 (-0.63%)

13:46
05/23/17
05/23
13:46
05/23/17
13:46
Conference/Events
Plains GP Holdings and Plains All American Pipeline host investor day meeting »

Investor Day Meeting will…

PAA

Plains All American

$27.83

-0.22 (-0.78%)

PAGP

Plains GP Holdings

$28.27

-0.18 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Aug

  • 08

    Nov

  • 08

    Nov

TWLO

Twilio

$25.19

0.23 (0.92%)

13:43
05/23/17
05/23
13:43
05/23/17
13:43
Hot Stocks
Before the Move: Canaccord sees Twilio conference rebuilding investor trust »

Cloud communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.